Published by You may be entitled to compensation by filing a Mounjaro Stomach Paralysis Lawsuit and our lawyers can help. Please click the button below for a Free Confidential Case Evaluation or call our law firm today by dialing (866) 588-0600.
Table Of Contents
- Mounjaro Lawsuit Overview
- Latest Mounjaro Lawsuit 2025 Updates
- FDA Reports and Statistics
- Mounjaro Injuries & Side Effects
- Do You Qualify for a Mounjaro Lawsuit?
- Mounjaro Recall Information
- Mounjaro Maker Sued Over “Stomach Paralysis” Claims: NBC News Video
- Statute of Limitations for Mounjaro Lawsuits
- FAQs
- 1. What is Mounjaro and how does it work?
- 2. How does Mounjaro cause gastroparesis or stomach paralysis?
- 3. What are the early warning signs of gastroparesis from Mounjaro?
- 4. Can Mounjaro cause other digestive issues besides stomach paralysis?
- 5. What should I do if I suspect Mounjaro caused my stomach paralysis?
- 6. Is there any treatment for stomach paralysis caused by Mounjaro?
- 7. How strong is the evidence linking Mounjaro to gastroparesis?
- 8. How long does it take for stomach paralysis symptoms to appear after taking Mounjaro?
- 9. What is the current status of Mounjaro lawsuits?
- 10. Do I need to pay anything upfront to file a Mounjaro lawsuit?
- Get Your Free Mounjaro Stomach Paralysis Lawsuit Evaluation With Our Lawyers
Mounjaro Lawsuit Overview
Lawsuits against Eli Lilly, the manufacturer of Mounjaro (tirzepatide), allege that the medication causes severe gastrointestinal injuries, particularly gastroparesis or stomach paralysis.
Plaintiffs claim that Eli Lilly failed to adequately warn about these serious risks despite having knowledge of them.
Over 1,300 cases are currently pending against Eli Lilly and other manufacturers of similar medications. The FDA has expressed concerns about the safety profile of GLP-1 medications used for weight loss.
Latest Mounjaro Lawsuit 2025 Updates
March 2025 – Over 1,300 pending cases against Eli Lilly and Novo Nordisk have been consolidated into multidistrict litigation (MDL) in the Eastern District of Pennsylvania, with the first federal trials expected to begin later in 2025.
February 2025 – The FDA issued additional warnings about the risks of gastroparesis associated with GLP-1 receptor agonists, emphasizing the need for comprehensive patient education about potential complications [1].
July 2024 – Jaclyn Bjorklund filed a lawsuit against Eli Lilly after experiencing severe gastrointestinal issues, persistent vomiting, and stomach pain following her switch from Ozempic to Mounjaro, resulting in tooth loss and multiple hospitalizations.
FDA Reports and Statistics
The FDA has noted that medications in the GLP-1 class, including Mounjaro, may be associated with an increased risk of gastroparesis, particularly in patients with pre-existing gastrointestinal issues [1].
Reports show a significant increase in adverse events related to GLP-1 receptor agonists since their expanded use for weight management.
Major concerns include:
- Hundreds of documented cases of severe gastrointestinal complications
- Multiple reports of gastroparesis requiring hospitalization
- Increasing instances of long-term digestive damage
The FDA has granted Mounjaro a “fast-track” designation for review to treat obesity in overweight individuals, despite these emerging safety concerns.
Mounjaro Injuries & Side Effects
Mounjaro users have reported a range of severe side effects, with gastrointestinal issues being particularly prominent.
- Gastroparesis (Stomach Paralysis): A condition causing the stomach to empty food at a significantly delayed rate, leading to serious digestive complications [2].
- Severe Vomiting: Chronic and excessive vomiting that can lead to tooth loss, dehydration, and electrolyte imbalances.
- Gastrointestinal Distress: Persistent abdominal pain, bloating, and discomfort that significantly impacts quality of life.
- Malnutrition: Inability to properly digest food leading to nutritional deficiencies and weight loss beyond what is considered healthy.
Do You Qualify for a Mounjaro Lawsuit?
You may qualify for a Mounjaro lawsuit if:
- You were prescribed and used Mounjaro for type 2 diabetes or weight loss
- You experienced severe gastrointestinal side effects, particularly gastroparesis (stomach paralysis)
- Your symptoms required medical intervention, such as hospitalization or ongoing treatment
- Your symptoms began after starting Mounjaro and were not present beforehand
- You can provide medical documentation connecting your injuries to Mounjaro use
Evidence Required for a Mounjaro Lawsuit
To build a strong case, you will need to gather:
- Complete medical records documenting your diagnosis, treatment plans, and complications related to Mounjaro use.
- Hospitalization records if you required emergency care for gastrointestinal issues.
- Results from diagnostic tests such as gastric emptying studies or other imaging that indicates gastroparesis.
- Prescription documentation showing dates, dosages, and prescribing physician information.
- Pharmacy records confirming your Mounjaro prescriptions.
- Documentation of all medical expenses related to treating your Mounjaro-induced conditions.
Damages You Can Recover
If your lawsuit is successful, you may be entitled to compensation for:
- Medical expenses for past and ongoing treatments
- Lost wages due to inability to work during recovery or ongoing disability
- Pain and suffering for physical pain and emotional distress
- Future medical care for managing chronic conditions like gastroparesis
- Loss of quality of life including impact on relationships and daily activities
Mounjaro Recall Information
As of April 2025, there has not been a formal recall of Mounjaro by the FDA or Eli Lilly. However, the increased scrutiny and growing number of lawsuits may influence future regulatory actions regarding the medication’s availability and labeling requirements.
Mounjaro Maker Sued Over “Stomach Paralysis” Claims: NBC News Video
Statute of Limitations for Mounjaro Lawsuits
The time frame to file a Mounjaro lawsuit varies by state but typically ranges from 1-3 years from the date you discovered or reasonably should have discovered your injury was related to Mounjaro use.
This “discovery rule” is particularly important in pharmaceutical cases where injuries may develop gradually over time.
Some states have specific regulations regarding pharmaceutical litigation that may impact these time limits. It is crucial to consult with an attorney as soon as possible to ensure your claim is filed within the appropriate timeframe.
Related Articles:
- Trulicity Stomach Paralysis Lawsuit
- Weight Loss Drug Stomach Paralysis Attorney
- Wegovy Stomach Paralysis Litigation
FAQs
1. What is Mounjaro and how does it work?
Mounjaro (tirzepatide) is a prescription medication approved by the FDA in May 2022 to treat type 2 diabetes. It works by increasing insulin production when blood sugar rises and decreasing the liver’s production of sugar. It is often prescribed “off-label” for weight loss despite only being FDA-approved for diabetes.
2. How does Mounjaro cause gastroparesis or stomach paralysis?
Mounjaro mimics incretin hormones and delays gastric emptying, meaning food stays in the stomach longer before moving into the small intestine. This delay can lead to gastroparesis, where the stomach muscles and nerves that control food movement don’t function correctly, resulting in severe digestive complications.
3. What are the early warning signs of gastroparesis from Mounjaro?
Early indicators include mild nausea, feeling full too soon after eating small amounts, and bloating after meals. If these symptoms appear, it’s important to consult your healthcare provider immediately.
4. Can Mounjaro cause other digestive issues besides stomach paralysis?
Yes, in addition to stomach paralysis, Mounjaro can cause other digestive issues such as severe constipation, diarrhea, and abdominal pain. These symptoms should be monitored closely and discussed with a healthcare provider.
5. What should I do if I suspect Mounjaro caused my stomach paralysis?
If you suspect that Mounjaro has caused stomach paralysis, seek medical attention immediately. Document your symptoms and medical history, then consult with a lawyer to explore legal options.
6. Is there any treatment for stomach paralysis caused by Mounjaro?
Treatment for gastroparesis typically includes dietary changes, medications to stimulate stomach muscles, and sometimes surgery. The specific treatment plan will depend on the severity of the condition and the individual’s health.
7. How strong is the evidence linking Mounjaro to gastroparesis?
The legal cases against Eli Lilly hinge on several compelling factors, including discrepancies between warnings and actual risks, prior knowledge of potential complications, and FDA communications expressing concerns about GLP-1 medications.
8. How long does it take for stomach paralysis symptoms to appear after taking Mounjaro?
Symptoms of stomach paralysis may develop gradually over time after starting Mounjaro. It could take weeks or even months for symptoms to become noticeable, so ongoing monitoring is essential.
9. What is the current status of Mounjaro lawsuits?
Over 1,300 pending cases against Eli Lilly and Novo Nordisk have been consolidated into multidistrict litigation in the Eastern District of Pennsylvania. The first federal trials are expected to begin in 2025.
10. Do I need to pay anything upfront to file a Mounjaro lawsuit?
Most attorneys handling Mounjaro lawsuits work on a contingency fee basis, meaning you don’t pay legal fees unless you receive compensation. Initial consultations are typically free and confidential.
Get Your Free Mounjaro Stomach Paralysis Lawsuit Evaluation With Our Lawyers
Time is limited to pursue legal action against Eli Lilly for Mounjaro-related injuries. Most states only allow you 1-3 years from the date of injury or discovery to file a claim. Don’t risk losing your right to compensation.
At Schmidt & Clark, LLP, we offer:
- Free, confidential consultations to evaluate your case
- No upfront costs or fees for our legal services
- Payment only if we win your case and secure compensation
- Nationwide representation in all 50 states
Don’t wait until it’s too late. Contact our experienced legal team today to understand your rights and options.
References:
- https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6874806/#:~:text=Gastroparesis%20is%20defined%20by%20a,obstruction%20of%20the%20gastric%20outlet.&text=Cardinal%20symptoms%20include%20post%2Dprandial,symptom%20in%20this%20disease2.